businesswire | September 21, 2023
Danimer Scientific, Inc. a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process.
Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics. The collaboration expands on Danimer and CPChem’s previously announced agreement, in which Danimer is evaluating the use of CPChem’s loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo™.
Stephen E. Croskrey, chief executive officer of Danimer, said, “Our business relationship with CPChem continues to yield results, and we’re excited for the further opportunities that lie ahead. CPChem’s Research and Technology lab in Bartlesville, Oklahoma, is a premier facility staffed with world-class talent that we believe will accelerate the path toward adoption of Rinnovo™ materials in high-volume applications that will assist in lowering the cost to serve key markets.”
Opened in 1950 by Phillips 66, CPChem’s Bartlesville facility contains first-class research equipment allowing for rapid testing of products across various processing conditions. Additionally, the facility’s testing and analytical capabilities provide a more rapid feedback loop, accelerating the development and optimization of resin formulations.
“We continue to be excited about the potential of our MarTECH® process technology and related collaborations to advance Danimer’s Rinnovo™, another CPChem initiative that can help accelerate change for a more sustainable future,” said Venki Chandrashekar, CPChem vice president of research and technology.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations.
prnewswire | September 12, 2023
Lummus Technology, a global provider of process technologies and value-driven energy solutions, and RWDC Industries, a biotechnology company developing biopolymer material solutions, announced a binding Joint Development and Commercial Cooperation Agreement (JDCCA) to rapidly expand manufacturing and global licensing of polyhydroxyalkanoates (PHA). In April, Lummus and RWDC signed a memorandum of understanding (MOU) to cooperate on global PHA deployment initiatives.
"This agreement highlights Lummus and RWDC's strong commitment to addressing plastic waste and the carbon footprint associated with conventional plastics production," said Leon de Bruyn, Lummus Technology's President and Chief Executive Officer. "Our partnership in this innovative space aligns with the United Nations' Sustainable Development Goals, reflecting our ongoing dedication to developing technologies that accelerate the use and availability of eco-friendly plastics."
"We look forward to the value that will be created in combining Lummus' expertise with ours to improve people's lives and health by making PHA polymers and resins available at large scale," said Dr. Daniel Carraway, RWDC's Chief Executive Officer. "It has always been our goal to develop sustainable materials that benefit every living thing on the planet, and this partnership is a monumental step in that direction. Lummus' and RWDC's decision to work together is an exciting development toward making it possible for more people to benefit from natural materials while preserving resources and our environment for future generations."
RWDC uses plant-based oils, including post-consumer or waste cooking oils, to produce its proprietary Solon™ PHA, which can be organically recycled or composted in home and industrial composting facilities. Products or packaging made with PHA that find their way into the environment, therefore, will fully biodegrade in soil, fresh water, and marine settings, preventing persistent plastics and microplastics from accumulating in the environment. Articles produced with PHA also can be recycled, re-used or returned to the carbon cycle by way of organic recycling or composting systems.
Lummus' interest in pursuing this partnership is testament to RWDC's attractiveness to licensors, due to its demonstrable technology innovation and technical capabilities; commercial value proposition and unit economics; and existing global brand partnerships that continuously validate market demand.
RWDC is uniquely positioned as the only PHA manufacturer in the market to provide scalable and cost-effective biopolymer production and first- and best-in-class formulation capabilities and guidance on conversion for product development. Licensing and technology development through its forthcoming partnership with Lummus further enhances RWDC's position as a market leader. Moreover, Lummus' polymer expertise, illustrated through its Novolen® polypropylene technology, highlights a commitment to innovation and sustainable solutions in polyolefin technology to drive transformative change within the plastics industry.
Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide.
About RWDC Industries
Founded in 2016, RWDC Industries is a biotechnology company that utilizes natural processes to produce materials for use in our daily lives. RWDC develops innovative, cost-effective biopolymer material solutions, including Solon™ PHA, a fully biodegradable and environmentally safe material that can replace plastic in a wide range of applications from single use articles to consumer goods or food packaging to non-wovens and textiles. RWDC supports sustainable practices and encourages responsible choice in plastic waste management, including recycling, to protect our environment and planet. Its global headquarters is in Singapore and operational headquarters is in Athens, Georgia.
businesswire | September 26, 2023
Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations.
Gilles Cottier, CEO at Actylis, said: “Today we are delighted to announce the opening of this new WFI system at our Baie d’Urfé site. Investment in this new WFI generation, storage, and distribution system reflects our ongoing commitment to support our customers, and to continuously develop our range of products and services. The new system positions us to be a preferred outsource partner for our customers’ buffer solutions. We understand that capacity is often a pinch-point for our customers, and we are delighted to be able to propose this option to them.”
Damien O’Rourke, SVP Manufacturing Operations at Actylis added: “Our new WFI system, redundant with our Limerick, Ireland WFI capabilities, incorporates the latest advancements in water purification technology, adhering to Good Manufacturing Practices (cGMP) that guarantees the production of WFI that meets or exceeds the most rigorous quality standards. In addition to the services this enables for our customers, the investment provides Actylis and our customers with a robust multi-site business continuity plan to ensure dependable supply.”
Jean-Francois Raymond, Site Director, elaborated on some of the specifics of the system: “We are excited to have this new system here at Baie d’Urfé come on stream. The WFI system is fully qualified with all supporting validation documents, and is capable of generating and maintaining water as per required USP and PhEur/BP specifications of Water for Injection.”
The new system’s strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond. Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands.
Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide.
Business Wire | September 28, 2023
908 Devices Inc. a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial production phase of the Aerosol and Vapor Chemical Agent Detector (AVCAD) program. The company and its partner on the project, Smiths Detection, will initially produce 122 systems in this next phase.
The systems, which have been in development and testing since 2019, are a next generation chemical detector, designed to detect, identify, alarm and report the presence of traditional and advanced threat vapors and aerosols. Using a wireless remote alarm capability, the AVCAD, which can be mounted or portable, will support missions for the U.S. Army, Navy, Coast Guard, and Marine Corps.
To ensure the highest level of detection and to meet the key deployment needs of the U.S. Department of Defense, the AVCAD features the company’s High Pressure Mass Spectrometry (HPMS) technology. Mass spectrometry is considered to be the gold standard of analytical lab techniques. 908 Devices’ proprietary HPMS technology leverages micro scale geometries and high frequency electronics to enable an efficient regime of vacuum operation for a significant reduction in device size and power consumption compared to conventional lab instruments.
“908 Devices is pleased to continue working with the U.S. Department of Defense and our partner, Smiths Detection, on this enterprise, multi-year program,” said Kevin J. Knopp, CEO and Co-founder of 908 Devices. “Being selected for this limited production phase validates our technology as a new standard for chemical detection and we are truly honored to have a role in protecting our U.S. military.”
About 908 Devices
908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma/biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic sampling and separations, software automation, and machine learning.